100 related articles for article (PubMed ID: 26200015)
21. Association of Systemic Lupus Erythematosus Disease Activity With Choroidal Thickness.
Lee I; Gomez AR; Kim AHJ; Coble DW; Marshall B; Shah A; Eisen S; Apte RS; Li T
J Clin Rheumatol; 2024 Mar; 30(2):e58-e62. PubMed ID: 37798827
[TBL] [Abstract][Full Text] [Related]
22. Mer-tyrosine kinase: a novel susceptibility gene for SLE related end-stage renal disease.
Yavuz S; Pucholt P; Sandling JK; Bianchi M; Leonard D; Bolin K; Imgenberg-Kreuz J; Eloranta ML; Kozyrev SV; Lanata CM; Jönsen A; Bengtsson AA; Sjöwall C; Svenungsson E; Gunnarsson I; Rantapää-Dahlqvist S; ; ; Nititham J; Criswell LA; Lindblad-Toh K; Rönnblom L
Lupus Sci Med; 2022 Nov; 9(1):. PubMed ID: 36332927
[TBL] [Abstract][Full Text] [Related]
23. Study on the Relationship between lncRNA Gene Polymorphism and Systemic Lupus Erythematosus.
Guan X; Liu D; Xing Y; Guan X
Comput Math Methods Med; 2022; 2022():4446016. PubMed ID: 35265170
[TBL] [Abstract][Full Text] [Related]
24.
Singh MK; Rallabandi HR; Zhou XJ; Qi YY; Zhao ZZ; Gan T; Zhang H; Looger LL; Nath SK
Ann Rheum Dis; 2024 Jun; 83(7):879-888. PubMed ID: 38373841
[TBL] [Abstract][Full Text] [Related]
25. Cardiovascular risk factors and complications in patients with systemic lupus erythematosus with and without nephritis: a systematic review and meta-analysis.
Wong CY; Ma BMY; Zhang D; Cheung W; Chan TM; Yap DYH
Lupus Sci Med; 2024 Mar; 11(1):. PubMed ID: 38519060
[TBL] [Abstract][Full Text] [Related]
26. Advances in the study of exosome-derived miRNAs in the pathogenesis, diagnosis, and treatment of systemic lupus erythematosus.
Wu Y; Dong HR; Liu LT; Peng ML; Su XL
Lupus; 2023 Nov; 32(13):1475-1485. PubMed ID: 37906972
[TBL] [Abstract][Full Text] [Related]
27. Expression profile of long-noncoding RNAs MIR31HG, NKILA, and PACER in systemic lupus erythematosus patients.
Alrefai AA; Abouelenin MAH; Salman MMA; Tawfeek GAE; Abbas MA
Clin Biochem; 2024 Apr; 126():110734. PubMed ID: 38395324
[TBL] [Abstract][Full Text] [Related]
28. The landscape of systemic lupus erythematosus in Brazil: An expert panel review and recommendations.
Klumb EM; Scheinberg M; Souza VA; Xavier RM; Azevedo VF; McElwee E; Restrepo MR; Monticielo OA
Lupus; 2021 Sep; 30(10):1684-1695. PubMed ID: 34255586
[TBL] [Abstract][Full Text] [Related]
29. Association of genetic variation on X chromosome with systemic lupus erythematosus in both Thai and Chinese populations.
Tangtanatakul P; Lei Y; Jaiwan K; Yang W; Boonbangyang M; Kunhapan P; Sodsai P; Mahasirimongkol S; Pisitkun P; Yang Y; Eu-Ahsunthornwattana J; Aekplakorn W; Jinawath N; Neelapaichit N; Hirankarn N; Wang YF
Lupus Sci Med; 2024 Mar; 11(1):. PubMed ID: 38458775
[TBL] [Abstract][Full Text] [Related]
30. [Analysis and precise intervention on pathogenic genes and mechanisms of lupus nephritis].
Zhang CM; Liu ZH
Zhonghua Yi Xue Za Zhi; 2024 Apr; 104(16):1367-1370. PubMed ID: 38644286
[TBL] [Abstract][Full Text] [Related]
31. Centrally acting ACE inhibitor (cACEi) and angiotensin receptor blocker (cARB) use and cognitive dysfunction in patients with SLE.
Dobrowolski C; Barraclough M; Su J; Tanic M; Bingham K; Ruttan L; Beaton D; Wither J; Tartaglia MC; Sano M; Kakvan M; Bonilla D; Green R; Touma Z
Lupus Sci Med; 2023 Jul; 10(2):. PubMed ID: 37429671
[TBL] [Abstract][Full Text] [Related]
32. Potential Small Molecules for Therapy of Lupus Nephritis Based on Genetic Effect and Immune Infiltration.
Qing J; Song W; Tian L; Samuel SB; Li Y
Biomed Res Int; 2022; 2022():2259164. PubMed ID: 35502341
[TBL] [Abstract][Full Text] [Related]
33.
Brady MP; Korte EA; Caster DJ; Powell DW
Lupus Sci Med; 2020 Oct; 7(1):. PubMed ID: 33122334
[TBL] [Abstract][Full Text] [Related]
34. Hospital Healthcare Resource Utilization and Associated Hospital Costs of Patients With Lupus Nephritis in China: A National Administrative Claim Database Study.
He X; Zhu X; Tang Z; Gairy K; Juliao P; Wu Z; Han S
Value Health Reg Issues; 2024 Jun; 43():101001. PubMed ID: 38850589
[TBL] [Abstract][Full Text] [Related]
35. Exacerbating effects of circadian rhythm disruption on the systemic lupus erythematosus.
Shen L; Han M; Luo X; Zhang Q; Xu H; Wang J; Wei N; Liu Q; Wang G; Zhou F
Lupus Sci Med; 2024 Apr; 11(1):. PubMed ID: 38599669
[TBL] [Abstract][Full Text] [Related]
36. A Prospective Study of the Impact of Current Poverty, History of Poverty, and Exiting Poverty on Accumulation of Disease Damage in Systemic Lupus Erythematosus.
Yelin E; Trupin L; Yazdany J
Arthritis Rheumatol; 2017 Aug; 69(8):1612-1622. PubMed ID: 28480630
[TBL] [Abstract][Full Text] [Related]
37. Development and validation of a risk scoring system to identify patients with lupus nephritis in electronic health record data.
Izadi Z; Gianfrancesco M; Anastasiou C; Schmajuk G; Yazdany J
Lupus Sci Med; 2024 May; 11(1):. PubMed ID: 38769054
[TBL] [Abstract][Full Text] [Related]
38. Local Ancestry at the Major Histocompatibility Complex Region is Not a Major Contributor to Disease Heterogeneity in a Multiethnic Lupus Cohort.
Solomon O; Lanata CM; Adams C; Nititham J; Taylor KE; Chung SA; Yazdany J; Dall'Era M; Pons-Estel BA; Tusié-Luna T; Tsao B; Morand E; Alarcón-Riquelme ME; Barcellos LF; Criswell LA
Arthritis Rheumatol; 2024 Apr; 76(4):614-619. PubMed ID: 38073021
[TBL] [Abstract][Full Text] [Related]
39. Letter to the editor: testing the effectiveness of MyPROSLE in classifying patients with lupus nephritis.
Leventhal EL; Daamen AR; Lipsky PE
Brief Bioinform; 2023 Sep; 24(5):. PubMed ID: 37670507
[TBL] [Abstract][Full Text] [Related]
40.
Fajar DR; Rostinawati T; Hamijoyo L; Sahiratmadja E; Amalia R; Barliana MI
Biologics; 2024; 18():95-106. PubMed ID: 38715569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
